Results 121 to 130 of about 24,314 (179)

Microsporidial keratoconjunctivitis after HAART

Clinical & Experimental Ophthalmology, 2001
ABSTRACTA 44‐year‐old man presented with bilateral punctate corneal epitheliopathy complaining of worsening discomfort and photophobia over the previous several days. He was HIV positive, had a recent CD4 count of 4 × 106, and had started on highly active antiretroviral therapy (HAART) 14 days prior.
A D, Gajdatsy, M L, Tay-Kearney
openaire   +2 more sources

Hungering for HAART

Annals of Internal Medicine, 2007
Expansion of highly active antiretroviral therapy (HAART) programs in South Africa and other low- and medium-income nations should remain a top priority.
Julio S.G. Montaner, Robert S. Hogg
openaire   +1 more source

Adherence to HAART Regimens

AIDS Patient Care and STDs, 2003
The problem of inadequate adherence to prescribed highly active antiretroviral therapy (HAART) drug regimens to treat HIV infection and AIDS is ubiquitous. Adherence can be inadequate despite both provider and patient understanding of the consequences of nonadherence.
openaire   +2 more sources

Ongoing HIV dissemination during HAART

Nature Medicine, 1999
Multiphasic HIV decrease in individuals treated with anti-retroviral drugs has been modeled as the independent decay, with different half-lives, of distinct pools of cells infected before the initiation of treatment. We analyzed the kinetics of plasma HIV RNA in individuals receiving combinations of up to five drugs.
Z, Grossman   +12 more
openaire   +2 more sources

The nephrotoxic effects of HAART

Nature Reviews Nephrology, 2009
With significant reductions in mortality and risk of progression to AIDS in the era of highly active antiretroviral therapy (HAART), complications of long-standing HIV infection and treatment have become increasingly important. Such complications include the nephrotoxic effects of HAART, which are the subject of this Review. The most common nephrotoxic
Hassane, Izzedine   +2 more
openaire   +2 more sources

HAART

Reactions Weekly, 2003
  +4 more sources

HAART

Inpharma Weekly, 1999
  +4 more sources

HAART

Reactions Weekly, 2002
openaire   +2 more sources

Home - About - Disclaimer - Privacy